Breast cancer
455 results
1 - 100
Breast surgery for metastatic breast cancer- Chinese medicine for immunological functions in women with breast cancer or a history of breast cancer
- Screening for breast cancer with mammography
- Timing of breast surgery in premenopausal breast cancer patients
- Partial breast irradiation versus whole breast radiotherapy for early breast cancer
- Specialist breast care nurses for support of women with breast cancer
- Oncoplastic breast‐conserving surgery for women with primary breast cancer
- Interventions for raising breast cancer awareness in women
- Cancer genetic risk assessment for individuals at risk of familial breast cancer
- Preoperative chemotherapy for women with operable breast cancer
- Fulvestrant for hormone‐sensitive metastatic breast cancer
- Trastuzumab containing regimens for early breast cancer
- Hypofractionated radiation therapy for early breast cancer
- Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk
- Toremifene versus tamoxifen for advanced breast cancer
- Psychological interventions for women with metastatic breast cancer
- Risk‐reducing mastectomy for the prevention of primary breast cancer
- Taxanes for adjuvant treatment of early breast cancer
- Skin‐sparing mastectomy for the treatment of breast cancer
- Trastuzumab‐containing regimens for metastatic breast cancer
- Antitumour antibiotic containing regimens for metastatic breast cancer
- Training health workers in clinical breast examination for early detection of breast cancer in low‐ and middle‐income countries
- Psychological interventions for women with non‐metastatic breast cancer
- Methods of communicating a primary diagnosis of breast cancer to patients
- Platinum‐containing regimens for metastatic breast cancer
- Exercise for women receiving adjuvant therapy for breast cancer
- Immediate versus delayed reconstruction following surgery for breast cancer
- Multidisciplinary rehabilitation for follow‐up of women treated for breast cancer
- Regular self‐examination or clinical examination for early detection of breast cancer
- Tamoxifen for early breast cancer: Cochrane systematic review
- Body weight management in overweight and obese breast cancer survivors
- Radiotherapy for early breast cancer: Cochrane systematic review
- Strategies for increasing the participation of women in community breast cancer screening
- Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women
- Prognostic factors for return to work in breast cancer survivors
- Surgical interventions for the prevention or treatment of lymphoedema after breast cancer treatment
- Risk‐reducing medications for primary breast cancer: a network meta‐analysis
- Single agent versus combination chemotherapy for metastatic breast cancer
- Mindfulness‐based stress reduction for women diagnosed with breast cancer
- Physical activity for women with breast cancer after adjuvant therapy
- Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen
- Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer
- Ovarian ablation for early breast cancer: Cochrane systematic review
- Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer
- LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women
- Systemic therapy for treating locoregional recurrence in women with breast cancer
- Addition of drug/s to a chemotherapy regimen for metastatic breast cancer
- Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery
- Chinese medicinal herbs to treat the side‐effects of chemotherapy in breast cancer patients
- Follow‐up strategies for women treated for early breast cancer
- Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review
- Combination versus sequential single agent chemotherapy for metastatic breast cancer
- PARP (Poly ADP‐Ribose Polymerase) inhibitors for locally advanced or metastatic breast cancer
- Taxane-containing regimens for metastatic breast cancer: Cochrane systematic review
- Ovarian suppression for adjuvant treatment of hormone receptor‐positive early breast cancer
- Multi-agent chemotherapy for early breast cancer: Cochrane systematic review
- Post‐mastectomy radiotherapy for women with early breast cancer and one to three positive lymph nodes
- Bisphosphonates and other bone agents for breast cancer: Cochrane systematic review
- Platinum‐containing regimens for triple‐negative metastatic breast cancer
- Capecitabine for hormone receptor‐positive versus hormone receptor‐negative breast cancer
- Sequencing of chemotherapy and radiotherapy for early breast cancer: Cochrane systematic review
- Risk‐reducing mastectomy for unaffected women with a strong family history of breast cancer
- Platinum‐based chemotherapy for early triple‐negative breast cancer
- Yoga for improving health‐related quality of life, mental health and cancer‐related symptoms in women diagnosed with breast cancer
- Shared decision‐making for supporting women’s decisions about breast cancer screening
- Exercise therapies for preventing or treating aromatase inhibitor‐induced musculoskeletal symptoms in early breast cancer
- Nipple- and areola-sparing mastectomy for the treatment of breast cancer: Cochrane systematic review
- Non-hormonal interventions for hot flushes in women with a history of breast cancer: Cochrane systematic review
- Online support groups for women with breast cancer: Cochrane systematic review
- Immune checkpoint inhibitors and chemotherapy versus chemotherapy for early triple‐negative breast cancer
- Exercise interventions for upper-limb dysfunction due to breast cancer treatment: Cochrane systematic review
- Vascular‐endothelial‐growth‐factor (VEGF) targeting therapies for endocrine refractory or resistant metastatic breast cancer
- Systemic therapies for preventing or treating aromatase inhibitor‐induced musculoskeletal symptoms in early breast cancer
- Paravertebral anaesthesia with or without sedation versus general anaesthesia for women undergoing breast cancer surgery
- Home-based multidimensional survivorship programmes for breast cancer survivors: Cochrane systematic review
- Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus)
- Axillary treatment for operable primary breast cancer: Cochrane systematic review
- Manual lymphatic drainage for lymphedema following breast cancer treatment: Cochrane systematic review
- High‐dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with metastatic breast cancer
- Regional analgesia techniques for postoperative pain after breast cancer surgery: a network meta‐analysis
- Tamoxifen or letrozole versus standard methods for women with estrogen-receptor positive breast cancer undergoing oocyte or embryo cryopreservation in assisted reproduction: Cochrane systematic review
- Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients: Cochrane systematic review
- High‐dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer
- Bone‐modifying agents for reducing bone loss in women with early and locally advanced breast cancer: a network meta‐analysis
- Conservative interventions for preventing clinically detectable upper-limb lymphoedema in patients who are at risk of developing lymphoedema after breast cancer therapy: Cochrane systematic review